KBP Biosciences is a global clinical stage biopharmaceutical company focused on the development of an innovative pipeline of new chemical entities with known mechanisms of action targeting underserved
patient populationsin organ protection and infectious diseases. KBP utilizes an integrated discovery and development platform that enables the Company
to efficiently bring new therapies from bench to patients around the world. ...
KBP Biosciences is a global clinical stage biopharmaceutical company focused on the development of an innovative pipeline of new chemical entities with known mechanisms of action targeting underserved
patient populationsin organ protection and infectious diseases. KBP utilizes an integrated discovery and development platform that enables the Company
to efficiently bring new therapies from bench to patients around the world. Our lead product candidate, KBP-5074, is a third-generation non-steroidal mineralocorticoid receptor
antagonist (MRA) with a potentially best-in-class safety and efficacy profile.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.